KEXING BIOPHARM SAYS UPDATES APPLICATION TO HONG KONG EXCHANGE FOR H-SHARE
LISTING. COMPANY FIRST FILED NO. 6, 2025 AND UPDATED FILING ON MAY 6, 2026.
LISTING SUBJECT TO REGULATORY APPROVALS
2026-05-07
KEXING BIOPHARM SAYS UPDATES APPLICATION TO HONG KONG EXCHANGE FOR H-SHARE
LISTING. COMPANY FIRST FILED NO. 6, 2025 AND UPDATED FILING ON MAY 6, 2026.
LISTING SUBJECT TO REGULATORY APPROVALS